Haak E, Usadel K H, Kusterer K, Amini P, Frommeyer R, Tritschler H J, Haak T
Medical Department I, Center of Internal Medicine, University Hospital, Frankfurt, Germany.
Exp Clin Endocrinol Diabetes. 2000;108(3):168-74. doi: 10.1055/s-2000-7739.
Diabetic polyneuropathy is a serious complication in patients with diabetes mellitus. In addition to the maintenance of a sufficient metabolic control, alpha-lipoic acid (ALA) (Thioctacid, Asta Medica) is known to have beneficial effects on diabetic polyneuropathy although the exact mechanism by which ALA exerts its effect is unknown. In order to study the effect of ALA on microcirculation in patients with diabetes mellitus and peripheral neuropathy one group of patients (4 female, 4 male, age 60+/-3 years, diabetes duration 19+/-4 years, BMI 24.8+/-1.3 kg/m2) received 1200 mg ALA orally per day over 6 weeks (trial 1). A second group of patients (5 female, 4 male, age 65+/-3 years, diabetes duration 14+/-4 years, BMI 23.6+/-0.7 kg/m2) was studied before and after they had received 600 mg ALA or placebo intravenously over 15 minutes in order to investigate whether ALA has an acute effect on microcirculation (trial 2). Patients were investigated by nailfold video-capillaroscopy. Capillary blood cell velocity was examined at rest and during postreactive hyperemia (occlusion of the wrist for 2 minutes, 200 mmHg) which is a parameter of the perfusion reserve on demand. The oral therapy with ALA resulted in a significant decrease in the time to peak capillary blood cell velocity (tpCBV) during postocclusive hyperemia (trial 1: 12.6+/-3.1 vs 35.4+/-10.9 s, p<0.05). The infusion of ALA also decreased the tpCBV in patients with diabetic neuropathy (trial 2: before: 20.8+/-4,5, ALA: 11.74+/-4.4, placebo: 21.9-5.0 s, p<0.05 ALA vs both placebo and before infusions) indicating that ALA has an acute effect on microcirculation. Capillary blood cell velocity at rest (rCBV), hemodynamic parameters, hemoglobinA1c and local skin temperature remained unchanged in both studies. These results demonstrate that in patients with diabetic polyneuropathy ALA improves microcirculation as indicated by an increased perfusion reserve on demand. The observed effects are apparently acute effects. With the restriction of the pilot character of this investigation the findings support the assumption that ALA might exert its beneficial effects at least partially by improving microcirculation which is likely to occur also at the level of the vasa nervorum.
糖尿病性多发性神经病是糖尿病患者的一种严重并发症。除了维持充分的代谢控制外,已知α-硫辛酸(ALA)(硫辛酸,阿斯塔制药公司)对糖尿病性多发性神经病有有益作用,尽管ALA发挥作用的确切机制尚不清楚。为了研究ALA对糖尿病和周围神经病变患者微循环的影响,一组患者(4名女性,4名男性,年龄60±3岁,糖尿病病程19±4年,体重指数24.8±1.3kg/m²)在6周内每天口服1200mgALA(试验1)。第二组患者(5名女性,4名男性,年龄65±3岁,糖尿病病程14±4年,体重指数23.6±0.7kg/m²)在静脉注射600mgALA或安慰剂15分钟前后接受研究,以调查ALA是否对微循环有急性作用(试验2)。通过甲襞视频毛细血管镜检查对患者进行研究。在静息状态和反应性充血期间(手腕压迫2分钟,200mmHg)检查毛细血管血细胞速度,反应性充血是按需灌注储备的一个参数。ALA口服治疗导致闭塞后充血期间毛细血管血细胞速度峰值时间(tpCBV)显著缩短(试验1:12.6±3.1对35.4±10.9秒,p<0.05)。ALA输注也降低了糖尿病神经病变患者的tpCBV(试验2:治疗前:20.8±4.5,ALA:11.74±4.4,安慰剂:21.9 - 5.0秒,ALA与安慰剂及输注前相比p<0.05),表明ALA对微循环有急性作用。两项研究中静息状态下的毛细血管血细胞速度(rCBV)、血流动力学参数、糖化血红蛋白A1c和局部皮肤温度均保持不变。这些结果表明,在糖尿病性多发性神经病患者中,按需灌注储备增加表明ALA改善了微循环。观察到的效应显然是急性效应。鉴于本研究的初步性质,这些发现支持以下假设:ALA可能至少部分通过改善微循环发挥其有益作用,而这种改善可能也发生在神经血管水平。